Intersect Stock Analysis

XENT -  USA Stock  

USD 16.34  0.39  2.33%

The newest drop in stock price may raise some interest from private investors as it is trading at a share price of 16.34 on very low momentum in trading volume. The company management teams have failed to build on market volatilities in May. However, diversifying your overall positions with Intersect Ent may protect your principal portfolio during upcoming market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 2.75. The current volatility is consistent with the ongoing market swings in May 2021 as well as with Intersect Ent unsystematic, company-specific events.
Check out Your Current Watchlist.

Search Stock Analysis 

 
Refresh
The Intersect Ent stock analysis report makes it easy to digest most publicly released information about Intersect Ent and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Intersect stock analysis module also helps to analyze the Intersect Ent price relationship with some important fundamental indicators such as market cap and management efficiency.

Intersect Stock Analysis Notes

About 93.0% of the company outstanding shares are owned by institutional investors. The company recorded a loss per share of 2.22. Intersect Ent had not issued any dividends in recent years. The entity had 1:4 split on the 11th of July 2014. Intersect ENT, Inc. operates as an ear, nose, and throat medical technology company in the United States. Intersect ENT, Inc. was incorporated in 2003 and is headquartered in Menlo Park, California. Intersect Ent operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 406 people. For more information please call Lisa Earnhardt at 650 641-2100 or visit www.intersectent.com.

Intersect Ent Quarterly Cost of Revenue

8.46 MillionShare

Intersect Ent Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Intersect Ent's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Intersect Ent or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Intersect Ent generates negative expected return over the last 90 days
The company reported the previous year's revenue of 85.06 M. Net Loss for the year was (74.82 M) with profit before overhead, payroll, taxes, and interest of 57.15 M.
Intersect Ent currently holds about 70.52 M in cash with (46.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.13.
Over 93.0% of the company outstanding shares are owned by institutional investors
Latest headline from www.equities.com: Intersect ENT Inc falls -0.3010 percent for June 11 - Equities.com

Intersect Ent Upcoming and Recent Events

Earnings reports are used by Intersect Ent to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Intersect Ent previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report3rd of August 2021
Next Earnings Report1st of November 2021
Next Fiscal Quarter End30th of June 2021
Next Fiscal Year End8th of March 2022
Last Quarter Report31st of March 2021
Last Earning Announcement30th of June 2020

Intersect Largest EPS Surprises

Earnings surprises can significantly impact Intersect Ent's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2018-08-01
2018-06-30-0.164-0.140.02414 
2015-08-05
2015-06-30-0.26-0.230.0311 
2017-11-02
2017-09-30-0.1933-0.150.043322 
View All Earnings Estimates

Intersect Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Intersect Ent is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Intersect Ent backward and forwards among themselves. Intersect Ent's institutional investor refers to the entity that pools money to purchase Intersect Ent's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Artisan Partners Limited PartnershipCommon Shares3.8 M78.7 M
Blackrock IncCommon SharesM62.1 M
Fmr LlcCommon Shares2.8 M57.6 M
First Light Asset Management LlcCommon SharesM42.5 M
Vanguard Group IncCommon Shares1.7 M35.6 M
Great Point Partners LlcCommon Shares1.3 M27.8 M
Rock Springs Capital Management LpCommon Shares1.1 M22.6 M
Note, although Intersect Ent's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Intersect Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 554.37 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Intersect Ent's market, we take the total number of its shares issued and multiply it by Intersect Ent's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Intersect Profitablity

Intersect Ent's profitability indicators refer to fundamental financial ratios that showcase Intersect Ent's ability to generate income relative to its revenue or operating costs. If, let's say, Intersect Ent is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Intersect Ent's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Intersect Ent's profitability requires more research than a typical breakdown of Intersect Ent's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (87.96) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (66.8) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.67.
Last ReportedProjected for 2021
Return on Investment(54.40) (58.69) 
Return on Average Assets(38.54) (41.58) 
Return on Average Equity(78.15) (84.32) 
Return on Invested Capital(0.27) (0.29) 
Return on Sales(0.39) (0.42) 

Management Efficiency

The entity has return on total asset (ROA) of (20.51) % which means that it has lost $20.51 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (93.45) %, meaning that it created substantial loss on money invested by shareholders. Intersect Ent management efficiency ratios could be used to measure how well intersect ent manages its routine affairs as well as how well it operates its assets and liabilities. Return on Investment is likely to drop to -58.69 in 2021. Return on Average Assets is likely to drop to -41.58 in 2021. Intersect Ent Total Liabilities is comparatively stable at the moment as compared to the past year. Intersect Ent reported Total Liabilities of 160.37 Million in 2020. Current Liabilities is likely to gain to about 47.7 M in 2021, whereas Liabilities Non Current is likely to drop slightly above 1.1 M in 2021.
Last ReportedProjected for 2021
Book Value per Share 4.17  4.50 
Enterprise Value over EBIT(19.80) (21.36) 
Enterprise Value over EBITDA(27.23) (29.38) 
Price to Book Value 5.57  6.67 
Tangible Assets Book Value per Share 5.92  7.96 
Enterprise Value549.9 M505.3 M
Tangible Asset Value130.2 M140.4 M

Technical Drivers

As of the 19th of June, Intersect Ent retains the risk adjusted performance of (0.06), and Market Risk Adjusted Performance of 0.4537. Concerning fundamental indicators, the technical analysis model lets you check existing technical drivers of Intersect Ent, as well as the relationship between them. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for Intersect Ent, which can be compared to its competitors. Please check out Intersect Ent standard deviation, as well as the relationship between the value at risk and kurtosis to decide if Intersect Ent is priced fairly, providing market reflects its last-minute price of 16.34 per share. Given that Intersect Ent has jensen alpha of (0.29), we strongly advise you to confirm Intersect Ent's regular market performance to make sure the company can sustain itself at a future point.

Intersect Ent Price Movement Analysis

The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Mid-point over period is an average of Intersect Ent highest and lowest values attained during the given period. View also all equity analysis or get more info about midpoint over period overlap studies indicator.

Intersect Ent Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Intersect Ent insiders, such as employees or executives, is commonly permitted as long as it does not rely on Intersect Ent's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Intersect Ent insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Teresa Kline over a week ago via Macroaxis 
Acquisition by Teresa Kline of 5734 shares of Intersect Ent subject to Rule 16b-3
Sandoval Elisabeth over two months ago via Macroaxis 
Acquisition by Sandoval Elisabeth of 15896 shares of Intersect Ent subject to Rule 16b-3
Hattangadi Neil A over two months ago via Macroaxis 
Acquisition by Hattangadi Neil A of 13993 shares of Intersect Ent subject to Rule 16b-3
Teresa Kline over three months ago via Macroaxis 
Acquisition by Teresa Kline of 3390 shares of Intersect Ent subject to Rule 16b-3
Thomas West over three months ago via Macroaxis 
Payment of 5013 shares by Thomas West of Intersect Ent subject to Rule 16b-3
Frederic Moll over three months ago via Macroaxis 
Exercise or conversion by Frederic Moll of 12500 shares of Intersect Ent subject to Rule 16b-3
Thomas West over three months ago via Macroaxis 
Acquisition by Thomas West of 118461 shares of Intersect Ent subject to Rule 16b-3
Gwen Carscadden over three months ago via Macroaxis 
Payment of 1416 shares by Gwen Carscadden of Intersect ENT subject to Rule 16b-3
Fernandez Reyna M over six months ago via Macroaxis 
Acquisition by Fernandez Reyna M of 29993 shares of Intersect ENT subject to Rule 16b-3
Meier Richard A over six months ago via Macroaxis 
Payment of 6349 shares by Meier Richard A of Intersect ENT subject to Rule 16b-3
Thomas West over six months ago via Macroaxis 
Payment of 16830 shares by Thomas West of Intersect ENT subject to Rule 16b-3
Teresa Kline over a year ago via Macroaxis 
Acquisition by Teresa Kline of 9666 shares of Intersect ENT subject to Rule 16b-3

Intersect Ent Technical and Predictive Indicators

Intersect Ent Forecast Models

Intersect Ent time-series forecasting models is one of many Intersect Ent's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Intersect Ent's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Intersect Ent Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Intersect Ent stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Intersect shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Intersect Ent. By using and applying Intersect Stock analysis, traders can create a robust methodology for identifying Intersect entry and exit points for their positions.
Last ReportedProjected for 2021
Operating Margin(83.98) (90.61) 
EBITDA Margin(82.18) (84.35) 
Gross Margin 62.38  62.38 
Profit Margin(89.78) (96.87) 
Intersect ENT, Inc. operates as an ear, nose, and throat medical technology company in the United States. Intersect ENT, Inc. was incorporated in 2003 and is headquartered in Menlo Park, California. Intersect Ent operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 406 people.

Current Intersect Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Intersect analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Intersect analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
23.0Hold7Odds
Intersect Ent current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Intersect analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Intersect stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Intersect Ent, talking to its executives and customers, or listening to Intersect conference calls.
Intersect Analyst Advice Details

Intersect Stock Analysis Indicators

Intersect Ent stock analysis indicators help investors evaluate how Intersect Ent stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Intersect Ent shares will generate the highest return on investment. By understating and applying Intersect Ent stock analysis, traders can identify Intersect Ent position entry and exit signals to maximize returns.
Quick Ratio1.96
Fifty Two Week Low11.66
Revenue Growth22.70%
Shares Short Prior Month940.45k
Average Daily Volume Last 10 Day121.42k
Average Daily Volume In Three Month172.35k
Shares Percent Shares Out3.14%
Gross Margins67.84%
Short Percent Of Float3.15%
Forward Price Earnings-13.28
Float Shares32.95M
Fifty Two Week High26.98
Enterprise Value To Ebitda-10.45
Fifty Day Average18.73
Two Hundred Day Average21.42
Enterprise Value To Revenue6.54
Check out Your Current Watchlist. Note that the Intersect Ent information on this page should be used as a complementary analysis to other Intersect Ent's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Commodity Channel Index module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Intersect Ent Stock analysis

When running Intersect Ent price analysis, check to measure Intersect Ent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intersect Ent is operating at the current time. Most of Intersect Ent's value examination focuses on studying past and present price action to predict the probability of Intersect Ent's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Intersect Ent's price. Additionally, you may evaluate how the addition of Intersect Ent to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
The market value of Intersect Ent is measured differently than its book value, which is the value of Intersect that is recorded on the company's balance sheet. Investors also form their own opinion of Intersect Ent's value that differs from its market value or its book value, called intrinsic value, which is Intersect Ent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intersect Ent's market value can be influenced by many factors that don't directly affect Intersect Ent underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intersect Ent's value and its price as these two are different measures arrived at by different means. Investors typically determine Intersect Ent value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intersect Ent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.